Journal
SCIENTIFIC REPORTS
Volume 13, Issue 1, Pages -Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41598-023-28299-4
Keywords
-
Categories
Ask authors/readers for more resources
225Ac is a radio-isotope used in targeted alpha therapy for treating distributed cancers. However, the shortage of pure 225Ac poses a challenge for developing 225Ac-labelled radiopharmaceuticals. One of the investigated techniques to obtain pure 225Ac is high-energy proton spallation of thorium or uranium combined with resonant laser ionization and mass separation. In this study, off-line resonant ionization mass spectrometry was performed on two samples of 225Ac, revealing operational collection efficiencies of 10.1(2)% and 9.9(8%) for different chemical environments.
225Ac is a radio-isotope that can be linked to biological vector molecules to treat certain distributed cancers using targeted alpha therapy. However, developing 225Ac-labelled radiopharmaceuticals remains a challenge due to the supply shortage of pure 225Ac itself. Several techniques to obtain pure 225Ac are being investigated, amongst which is the high-energy proton spallation of thorium or uranium combined with resonant laser ionization and mass separation. As a proof-of-principle, we perform off-line resonant ionization mass spectrometry on two samples of 225Ac, each with a known activity, in different chemical environments. We report overall operational collection efficiencies of 10.1(2)% and 9.9(8)% for the cases in which the 225Ac was deposited on a rhenium surface and a ThO2 mimic target matrix respectively. The bottleneck of the technique was the laser ionization efficiency, which was deduced to be 15.1(6)%.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available